Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $153.2450 (2.83%) ($153.2450 - $153.2450) on Wed. Mar. 31, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.21% (three month average) | RSI | 49 | Latest Price | $153.2450(2.83%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1.3% a day on average for past five trading days. | Weekly Trend | LGND declines -3.3% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) IWM(55%) IWC(53%) XBI(52%) | Factors Impacting LGND price | LGND will decline at least -2.605% in a week (0% probabilities). VIXM(-27%) VXX(-17%) UUP(-17%) UNG(-3%) TBT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.605% (StdDev 5.21%) | Hourly BBV | 0.1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $153.86 | 5 Day Moving Average | $151.8(0.95%) | 10 Day Moving Average | $153.55(-0.2%) | 20 Day Moving Average | $153.86(-0.4%) | To recent high | -29% | To recent low | 54.2% | Market Cap | $2.463b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |